Small Cap Feast

8th January 2024

Dish of the day
No Joiners today
Off the menu
No leavers today
Happy New Year to all our Readers!

Dish Of The Day:


Admissions whilst we were away: 
18 December 2023: Good Life Plus (AQSE: GDLF) joined the Access Segment of the Aquis Stock Exchange following a reverse take-over. Formally Semper Fortis Esports Plc, Good Life Plus operates an entertainment focused monthly subscription service for consumers that provides access to daily luxury prize draws, along with numerous offers, discounts and rewards. Gross proceeds raised upon Admission of £1.4m at a price of 2 pence per share. Market Capitalisation on Admission was approximately £12.58m. 
20 December 2023: EnergyPathways Plc (EPP.L) - Formally Dial Square Investments which was listed on the Standard Listing of the Main Market transferred from the Main Market and joined the AIM Market via an acquisition of EnergyPathways Limited which constituted a reverse take-over. The Company raised gross proceeds of £2m at a price of 4 pence per share. Market Capitalisation on Admission of approximately £6.32m. 
21 December 2023: Kondor AI ITF: A U.K. registered AI company planning to launch the Kondor AI app, which will analyse pictures and live photos and provide solutions to questions and challenges based on visual input, successfully completed its Admission to the AQSE Growth Market. 
4 January 2024: SigmaRoc (SRC.L) announces its Admission to AIM following a reverse take-over after the Company announced it entered into an agreement to acquire certain European lime businesses from CRH plc (CRH) comprising of standalone businesses in Germany, the Czech Republic and Ireland (Deal 1 Targets). The total consideration payable by SigmaRoc for the Deal 1 Targets was EUR745m (£645m). The Company raised £198.8m from the Placing and £1.2m from the Retail Offer. Market capitalisation on Admission was c.£530m (at an issue price of 47.5 pence) and the share opened at 53.4p, a market capitalisation of £595.3m.

Delistings whilst we were away and today: 
18 December: Yooma Wellness Inc (AQSE: YOOM) withdrew from the Aquis Market 
19 December: Reconstruction Capital II Ltd (RC2.L) left AIM 
20 December: Gresham House Plc (GHE.L) left AIM 
22 December: Wentworth Resources Plc (WEN.L) left AIM 
22 December: Restaurant Grp Plc (RTN.L) left AIM 
27 December: Deepverge Plc (DVRG.L) left AIM 
27 December: Scotgold Resources Plc (SGZ.L) left AIM 
28 December: Scotgold Resources Plc (AQSE: SGZ) withdrew from the Aquis Market where it was dual listed 
02 January 2024: Guanajuato Silver Company (AQSE: GSVR) withdrew from the Aquis Market 
04 January: Petroneft Resources Plc (PTR.L) left AIM 
04 January: MBH Corporation (AQSE: M8H) withdrew from the Aquis Market 
05 January: Real Good Food Plc (RGD.L) left AIM 
08 January: Online Blockchain Plc (OBC.L) left AIM 
08 January: Tintra Plc (TNT.L) left AIM




Whats baking in the oven?

Potential Initial Public Offerings:

None


Reverse Takeovers:

None


Change of Market:
05 December: AdvancedAdvT Limited (ADVT.L):
Intends to delist from its Standard Listing of the Main Market on 10 January and apply for the Admission of its shares to trading on AIM on 10 January 2024. The Company will not raise additional capital on Admission. Anticipated market capitalisation on Admission is c.£109m (based on the pre suspension price of 82 pence per share).


Banquet Buffet

Arecor Therapeutics 174p £53.3m (AREC.L)
The biopharmaceutical group announces the expansion of its ongoing, exclusive formulation study collaboration with one of the world's largest chemicals marketing and pharmaceuticals companies, which focuses on the development and commercialisation of speciality drugs. The collaboration since it began in November 2022 uses Arecor’s proprietary formulation technology platform, Arestat™, to develop a differentiated, ready-to-use liquid formulation of its partner's product, AT351. Arecor will undertake additional in-house activities to accelerate the development programme and progress towards its partner's Pre-Investigational New Drug (Pre-IND) meeting with the US FDA.

Celebrus Technologies 236p £93.5m (CLBS.L)
The data solutions provider announces several contract wins made during the quarter to 31 December 2023: (1) a three-year deal with a new customer; a European retailer of experience gifts; (2) a contract with an existing top 10 banking customer, which has renewed its multi-million dollar annual license for a further three years, increasing ARR to the Group by 19% from the original contract; (3) a contract win with a UK bank for a three-year multi-million dollar contract for the full Celebrus platform; (4) a three-year contract with a new customer in the US healthcare sector.

CMO Group 24p £17.3m (CMO.L)
The online-only retailer of building materials, announces an update for the full year to 31 December 2023. As consumers shifted towards smaller projects due to the ongoing economic challenges and average orders values were lower in the latter part of 2023. The total sales for the year to 31 December 2023 are expected to be broadly in-line at c.£71.5m (2022: £83.1m), full-year adjusted EBITDA is expected to be c.£1m (2022: £2.1m), below previous guidance. The Group remains well financed with cash of c. £4.3m (FY22: £6.2m) and net debt at 31 December 2023 of £1m (FY22: net cash £1.4m).

Croma Security Solutions 67p £9.2m (CSSG.L)
The security solutions provider announces that it has completed the acquisition of two separate locksmith businesses for a combined cash consideration of £438k which includes a freehold property valued at £0.35m. The two locksmith businesses have a combined annual turnover of £0.5m and are a good fit with the Group's existing network. The acquisitions are part of the Group's ambitions to roll out its security centre network nationwide and takes the total number of centres to 16. There are further acquisition opportunities under consideration by management with the potential to transform more traditional locksmiths into modern security centres with stronger in-store product ranges and greater profit potential.

Emmerson 1.35p £13.9m (EML.L)
The company that is developing the Khemisset Potash Project in Morocco provides an update on activities during Q4 2023. Emmerson is still awaiting the session of the Commission Ministérielle de Pilotage to obtain environmental approval. In December 2023, the Company announced the extension of the appointment of a syndicate of international and Moroccan banks as initial mandated lead arrangers (MLAs) to co-ordinate and fund dual-tranche debt financing facilities for the development of the Project for a further 12 months until 31 December 2024. The debt facility under discussion amounts to US$310m, including an ECA-covered tranche of US$230m supported by UK Export Finance, and a dual currency (US$ and Moroccan Dirham) commercial tranche of US$80m.

Helium One Global 0.225p £7.7m (HE1.L)
The helium explorer in Tanzania announces that drilling at the Itumbula West-1 well commenced on 06 January 2024. Downhole reservoir testing equipment has been mobilised internationally to perform open hole well testing and fully evaluate the fault zones. Portable mass spectrometer and field pressure-volume-temperature specialist are on site to measure and validate helium gas shows as well as downhole samples. Baker Hughes, an energy technology company, continues to provide third party services for wireline, fluids and cementing. Part relinquishment of Prospecting Licence (PL) 10704/2015 in the Balangida Rift Basin, following an internal license review completed earlier last year, is now ratified by Tanzanian Government.

Huddled Group 3.85p £12.3m (HUD.L)
The company focused on building a portfolio of e-commerce brands, reports an update on unaudited results for the year ending 31 December 2023 (FY23). Revenue from continuing operations (constituting Discount Dragon and Let's Explore) is expected to be £2.2m, with almost all of this falling in the last quarter of the year during which the acquisition of Discount Dragon was completed and the Let's Explore division entered its peak trading period. Profit on disposal of the LBE and Uvisan divisions is £15m. Net cash was £4.2m as at 31 December 2023 and further cash of $1.25m is due to be received in February 2024 from the settlement of the loan note by the buyer of the Immotion Location Based Entertainment VR business.

Kibo Energy* 0.0375p £1.4m (KIBO.L)
The renewable energy-focused development company provides an update on its subsidiary Mast Energy Developments (MED) regarding MED’s Joint Venture Agreement (JVA) with Proventure Holdings (UK) Ltd, part of the Proventure Group. Proventure has still not made the first £1m payment to the Project Special Purpose Vehicle, which MED now understands was delayed due to a lack of coordination and administrative difficulties on the side of Proventure over the festive period. Proventure CEO, Mr. Kona, will travel to London soon to work with MED to expedite the delivery of the overdue payments, as well as to finalise the outstanding administration to complete the JVA transaction. MED is furthermore in discussions with respect to an alternative source of short-term funding to ensure that any further delays regarding the JVA will not unduly impact MED's operations.

MediaZest* 0.0425p £0.6m (MDZ.L)
The creative audio-visual company announces that it has raised a total of £120k (before expenses) via the issue of ordinary shares at a price of 0.04 pence per share. This represents a discount of approximately 6% to the closing middle market price of 0.0425 pence per share on 5 January 2024. The net proceeds will support working capital, business development and growth of the Company’s Dutch subsidiary to exploit new opportunities in the EU. The Company continues to sign regular repeat work on projects – often on a store by store or dealership by dealership basis. The value of MediaZest’s recurring revenue contracts has increased, with contracts currently running at around £700k per year on an annualised basis, some of which are multi-year deals. In addition, new European installations are predominantly geared towards strong recurring revenue streams and 3-year deals.

Surface Transforms 11.25p £39.6m (SCE.L)
The manufacturers of carbon fibre reinforced ceramic automotive brake discs, provides a trading update for the year to 31 December 2023 (FY23). Subject to audit, revenue for FY23 grew 63% to £8.3m (2022: £5.1m). Gross cash at 31 December 2023 was £6.1m, including the cash received from the December 2023 equity fundraising. The Company is maintaining its revenue guidance for 2024 at £23m. Overall, the outlook for 2024 to 2027 continues to remain positive reflecting contracts in series production and recent new business announcements, with capacity being installed to fulfil these awards.

8 January 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged

STAY INFORMED

Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram